Francesmary Modugno - Publications

Affiliations: 
University of Pittsburgh, Pittsburgh, PA, United States 
Area:
Public Health, Oncology, Genetics, Immunology

94 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Fu Z, Moysich K, Ness RB, Modugno F. Gender of offspring and risk of ovarian cancer: The HOPE study. Cancer Epidemiology. 64: 101646. PMID 31835157 DOI: 10.1016/j.canep.2019.101646  0.32
2019 Meagher NS, Wang L, Rambau PF, Intermaggio MP, Huntsman DG, Wilkens LR, El-Bahrawy MA, Ness RB, Odunsi K, Steed H, Herpel E, Anglesio MS, Zhang B, Lambie N, Swerdlow AJ, ... ... Modugno F, et al. A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 31239549 DOI: 10.1038/s41379-019-0302-0  0.32
2019 Harris HR, Cushing-Haugen KL, Webb PM, Nagle CM, Jordan SJ, Risch HA, Rossing MA, Doherty JA, Goodman MT, Modugno F, Ness RB, Moysich KB, Kjær SK, Høgdall E, et al. Association between genetically predicted polycystic ovary syndrome and ovarian cancer: a Mendelian randomization study. International Journal of Epidemiology. PMID 31211375 DOI: 10.1093/ije/dyz113  0.32
2019 Minlikeeva AN, Cannioto R, Jensen A, Kjaer SK, Jordan SJ, Diergaarde B, Szender JB, Odunsi K, Almohanna H, Mayor P, Starbuck K, Zsiros E, Bandera EV, Cramer DW, Doherty JA, ... ... Modugno F, et al. Joint exposure to smoking, excessive weight, and physical inactivity and survival of ovarian cancer patients, evidence from the Ovarian Cancer Association Consortium. Cancer Causes & Control : Ccc. PMID 30905014 DOI: 10.1007/s10552-019-01157-3  0.32
2019 Modugno F, Goughnour SL, Wallack D, Edwards RP, Odunsi K, Kelley JL, Moysich K, Ness RB, Brooks MM. Breastfeeding factors and risk of epithelial ovarian cancer. Gynecologic Oncology. PMID 30686553 DOI: 10.1016/j.ygyno.2019.01.017  0.32
2018 Yang Y, Wu L, Shu X, Lu Y, Shu XO, Cai Q, Beeghly-Fadiel A, Li B, Ye F, Berchuck A, Anton-Culver H, Banerjee S, Benitez J, Bjørge L, Brenton JD, ... ... Modugno F, et al. Genetic data from nearly 63,000 women of European descent predicts DNA methylation biomarkers and epithelial ovarian cancer risk. Cancer Research. PMID 30559148 DOI: 10.1158/0008-5472.CAN-18-2726  0.32
2018 Kim S, Wang M, Tyrer JP, Jensen A, Wiensch A, Liu G, Lee AW, Ness RB, Salvatore M, Tworoger SS, Whittemore AS, Anton-Culver H, Sieh W, Olson SH, Berchuck A, ... ... Modugno F, et al. A Comprehensive Gene-Environment Interaction Analysis in Ovarian Cancer using Genome-wide Significant Common Variants. International Journal of Cancer. PMID 30499236 DOI: 10.1002/ijc.32029  0.32
2018 Kelemen LE, Earp M, Fridley BL, Chenevix-Trench G, Fasching PA, Beckmann MW, Ekici AB, Hein A, Lambrechts D, Lambrechts S, Van Nieuwenhuysen E, Vergote I, Rossing MA, Doherty JA, ... ... Modugno F, et al. rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology. International Journal of Molecular Sciences. 19. PMID 30134598 DOI: 10.3390/ijms19092473  0.32
2018 Rambau PF, Vierkant RA, Intermaggio MP, Kelemen LE, Goodman MT, Herpel E, Pharoah PD, Kommoss S, Jimenez-Linan M, Karlan BY, Gentry-Maharaj A, Menon U, Hernando Polo S, Candido Dos Reis FJ, Doherty JA, ... ... Modugno F, et al. Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study. The Journal of Pathology. Clinical Research. PMID 30062862 DOI: 10.1002/cjp2.109  0.32
2018 Earp M, Tyrer JP, Winham SJ, Lin HY, Chornokur G, Dennis J, Aben KKH, Anton-Culver H, Antonenkova N, Bandera EV, Bean YT, Beckmann MW, Bjorge L, Bogdanova N, Brinton LA, ... ... Modugno F, et al. Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility. Plos One. 13: e0197561. PMID 29979793 DOI: 10.1371/journal.pone.0197561  0.32
2018 Dixon-Suen SC, Nagle CM, Thrift AP, Pharoah PDP, Ewing A, Pearce CL, Zheng W, Chenevix-Trench G, Fasching PA, Beckmann MW, Lambrechts D, Vergote I, Lambrechts S, Van Nieuwenhuysen E, ... ... Modugno F, et al. Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study. British Journal of Cancer. PMID 29555990 DOI: 10.1038/s41416-018-0011-3  0.32
2018 Block MS, Vierkant RA, Rambau PF, Winham SJ, Wagner P, Traficante N, Tołoczko A, Tiezzi DG, Taran FA, Sinn P, Sieh W, Sharma R, Rothstein JH, Ramón Y Cajal T, Paz-Ares L, ... ... Modugno F, et al. MyD88 and TLR4 Expression in Epithelial Ovarian Cancer. Mayo Clinic Proceedings. 93: 307-320. PMID 29502561 DOI: 10.1016/j.mayocp.2017.10.023  0.32
2018 Minlikeeva AN, Moysich KB, Mayor PC, Etter JL, Cannioto RA, Ness RB, Starbuck K, Edwards RP, Segal BH, Lele S, Odunsi K, Diergaarde B, Modugno F. Anthropometric characteristics and ovarian cancer risk and survival. Cancer Causes & Control : Ccc. PMID 29327114 DOI: 10.1007/s10552-017-0997-5  0.32
2017 Harris HR, Babic A, Webb PM, Nagle CM, Jordan SJ, Risch HA, Rossing MA, Doherty JA, Goodman MT, Modugno F, Ness RB, Moysich KB, Kjaer SK, Høgdall E, Jensen A, et al. Polycystic ovary syndrome, oligomenorrhea, and risk of ovarian cancer histotypes: Evidence from the Ovarian Cancer Association Consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 29141849 DOI: 10.1158/1055-9965.EPI-17-0655  0.32
2017 Goode EL, Block MS, Kalli KR, Vierkant RA, Chen W, Fogarty ZC, Gentry-Maharaj A, Toloczko A, Hein A, Bouligny AL, Jensen A, Osorio A, Hartkopf AD, Ryan A, ... ... Modugno F, et al. Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer. Jama Oncology. e173290. PMID 29049607 DOI: 10.1001/jamaoncol.2017.3290  0.32
2017 Minlikeeva AN, Freudenheim JL, Eng KH, Cannioto RA, Friel G, Szender JB, Segal B, Odunsi K, Mayor P, Diergaarde B, Zsiros E, Kelemen LE, Köbel M, Steed H, deFazio A, ... ... Modugno F, et al. History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association Consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 26: 1470-1473. PMID 28864456 DOI: 10.1158/1055-9965.EPI-17-0367  0.32
2017 Minlikeeva AN, Freudenheim JL, Cannioto RA, Eng KH, Szender JB, Mayor P, Etter JL, Cramer DW, Diergaarde B, Doherty JA, Dörk T, Edwards R, deFazio A, Friel G, Goodman MT, ... ... Modugno F, et al. History of thyroid disease and survival of ovarian cancer patients: results from the Ovarian Cancer Association Consortium, a brief report. British Journal of Cancer. PMID 28817835 DOI: 10.1038/bjc.2017.267  0.32
2017 Liu G, Lee S, Lee AW, Wu AH, Bandera EV, Jensen A, Anne Rossing M, Moysich KB, Chang-Claude J, Doherty J, Gentry-Maharaj A, Kiemeney L, Gayther SA, Modugno F, Massuger L, et al. Robust Tests for Additive Gene-Environment Interaction in Case-Control Studies Using Gene-Environment Independence. American Journal of Epidemiology. PMID 28633381 DOI: 10.1093/aje/kwx243  0.32
2017 Dixon SC, Nagle CM, Wentzensen N, Trabert B, Beeghly-Fadiel A, Schildkraut JM, Moysich KB, deFazio A, Risch HA, Rossing MA, Doherty JA, Wicklund KG, Goodman MT, Modugno F, et al. Use of common analgesic medications and ovarian cancer survival: results from a pooled analysis in the Ovarian Cancer Association Consortium. British Journal of Cancer. PMID 28350790 DOI: 10.1038/bjc.2017.68  0.32
2017 Minlikeeva AN, Freudenheim JL, Cannioto RA, Szender JB, Eng KH, Modugno F, Ness RB, LaMonte MJ, Friel G, Segal BH, Odunsi K, Mayor P, Zsiros E, Schmalfeldt B, Klapdor R, et al. History of hypertension, heart disease, and diabetes and ovarian cancer patient survival: evidence from the ovarian cancer association consortium. Cancer Causes & Control : Ccc. PMID 28293802 DOI: 10.1007/s10552-017-0867-1  0.32
2017 Kar SP, Adler E, Tyrer J, Hazelett D, Anton-Culver H, Bandera EV, Beckmann MW, Berchuck A, Bogdanova N, Brinton L, Butzow R, Campbell I, Carty K, Chang-Claude J, Cook LS, ... ... Modugno F, et al. Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci. British Journal of Cancer. PMID 28103614 DOI: 10.1038/bjc.2016.426  0.32
2017 Praestegaard C, Jensen A, Jensen SM, Nielsen TS, Webb PM, Nagle CM, DeFazio A, Høgdall E, Rossing MA, Doherty JA, Wicklund KG, Goodman MT, Modugno F, Moysich K, et al. Cigarette smoking is associated with adverse survival among women with ovarian cancer: results from a pooled analysis of 19 studies. International Journal of Cancer. PMID 28063166 DOI: 10.1002/ijc.30600  0.32
2016 Rasmussen CB, Kjaer SK, Albieri V, Bandera EV, Doherty JA, Høgdall E, Webb PM, Jordan SJ, Rossing MA, Wicklund KG, Goodman MT, Modugno F, Moysich KB, Ness RB, Edwards RP, et al. Pelvic Inflammatory Disease and the Risk of Ovarian Cancer and Borderline Ovarian Tumors: A Pooled Analysis of 13 Case-Control Studies. American Journal of Epidemiology. PMID 27941069 DOI: 10.1093/aje/kww161  0.32
2016 Permuth JB, Reid B, Earp M, Chen YA, Monteiro AN, Chen Z, Aocs Study Group, Chenevix-Trench G, Fasching PA, Beckmann MW, Lambrechts D, Vanderstichele A, Van Niewenhuyse E, Vergote I, Rossing MA, ... ... Modugno F, et al. Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration. Oncotarget. 7: 72381-72394. PMID 27911851 DOI: 10.18632/oncotarget.10546  0.32
2016 Clyde MA, Palmieri Weber R, Iversen ES, Poole EM, Doherty JA, Goodman MT, Ness RB, Risch HA, Rossing MA, Terry KL, Wentzensen N, Whittemore AS, Anton-Culver H, Bandera EV, Berchuck A, ... ... Modugno F, et al. Risk Prediction for Epithelial Ovarian Cancer in 11 United States-Based Case-Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic Loci. American Journal of Epidemiology. PMID 27698005 DOI: 10.1093/aje/kww091  0.32
2016 Sucheston-Campbell LE, Cannioto R, Clay AI, Etter JL, Eng KH, Liu S, Battaglia S, Hu Q, Szender JB, Minlikeeva A, Joseph J, Mayor P, Abrams SI, Segal B, Wallace PK, ... ... Modugno F, et al. No evidence that genetic variation in the myeloid-derived suppressor cell pathway influences ovarian cancer survival. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 27677730 DOI: 10.1158/1055-9965.EPI-16-0631  0.32
2016 Ong JS, Cuellar-Partida G, Lu Y, Ovarian Cancer Study A, Fasching PA, Hein A, Burghaus S, Beckmann MW, Lambrechts D, Van Nieuwenhuysen E, Vergote I, Vanderstichele A, Anne Doherty J, Anne Rossing M, Chang-Claude J, ... ... Modugno F, et al. Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study. International Journal of Epidemiology. PMID 27594614 DOI: 10.1093/ije/dyw207  0.32
2016 Hampras SS, Sucheston-Campbell LE, Cannioto R, Chang-Claude J, Modugno F, Dörk T, Hillemanns P, Preus L, Knutson KL, Wallace PK, Hong CC, Friel G, Davis W, Nesline M, Pearce CL, et al. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer. Oncotarget. PMID 27533245 DOI: 10.18632/oncotarget.10215  0.32
2016 Lee AW, Bomkamp A, Bandera EV, Jensen A, Ramus SJ, Goodman MT, Rossing MA, Modugno F, Moysich KB, Chang-Claude J, Rudolph A, Gentry-Maharaj A, Terry KL, Gayther SA, Cramer DW, et al. A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer. International Journal of Cancer. PMID 27420401 DOI: 10.1002/ijc.30274  0.32
2016 Dixon SC, Nagle CM, Thrift AP, Pharoah PD, Pearce CL, Zheng W, Painter JN, Chenevix-Trench AG, Fasching PA, Beckmann MW, Lambrechts D, Vergote I, Lambrechts S, Van Nieuwenhuysen E, Rossing MA, ... ... Modugno F, et al. Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study. International Journal of Epidemiology. PMID 27401727 DOI: 10.1093/ije/dyw158  0.32
2016 Cannioto RA, LaMonte MJ, Kelemen LE, Risch HA, Eng KH, Minlikeeva AN, Hong CC, Szender JB, Sucheston-Campbell L, Joseph JM, Berchuck A, Chang-Claude J, Cramer DW, DeFazio A, Diergaarde B, ... ... Modugno F, et al. Recreational physical inactivity and mortality in women with invasive epithelial ovarian cancer: evidence from the Ovarian Cancer Association Consortium. British Journal of Cancer. PMID 27299959 DOI: 10.1038/bjc.2016.153  0.32
2016 Cannioto R, LaMonte MJ, Risch HA, Hong CC, Sucheston-Campbell LE, Eng KH, Szender JB, Chang-Claude J, Schmalfeldt B, Klapdor R, Gower E, Minlikeeva AN, Zirpoli GR, Bandera EV, Berchuck A, ... ... Modugno F, et al. Chronic Recreational Physical Inactivity and Epithelial Ovarian Cancer Risk: Evidence from the Ovarian Cancer Association Consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 27197285 DOI: 10.1158/1055-9965.EPI-15-1330  0.32
2016 Cuellar-Partida G, Lu Y, Dixon SC, Fasching PA, Hein A, Burghaus S, Beckmann MW, Lambrechts D, Van Nieuwenhuysen E, Vergote I, Vanderstichele A, Doherty JA, Rossing MA, Chang-Claude J, ... ... Modugno F, et al. Assessing the genetic architecture of epithelial ovarian cancer histological subtypes. Human Genetics. PMID 27075448 DOI: 10.1007/s00439-016-1663-9  0.32
2016 Lee AW, Ness RB, Roman LD, Terry KL, Schildkraut JM, Chang-Claude J, Doherty JA, Menon U, Cramer DW, Gayther SA, Risch H, Gentry-Maharaj A, Goodman MT, Modugno F, Eilber U, et al. Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk. Obstetrics and Gynecology. PMID 27054934 DOI: 10.1097/AOG.0000000000001387  0.32
2016 Usset JL, Raghavan R, Tyrer JP, McGuire V, Sieh W, Webb P, Chang-Claude J, Rudolph A, Anton-Culver H, Berchuck A, Brinton LA, Cunningham JM, deFazio A, Doherty JA, Edwards RP, ... ... Modugno F, et al. Assessment of multifactor gene-environment interactions and ovarian cancer risk: candidate genes, obesity, and hormone-related risk factors. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 26976855 DOI: 10.1158/1055-9965.EPI-15-1039  0.32
2016 Præstegaard C, Kjaer SK, Nielsen TS, Jensen SM, Webb PM, Nagle CM, Høgdall E, Risch HA, Rossing MA, Doherty JA, Wicklund KG, Goodman MT, Modugno F, Moysich K, Ness RB, et al. The association between socioeconomic status and tumour stage at diagnosis of ovarian cancer: A pooled analysis of 18 case-control studies. Cancer Epidemiology. 41: 71-79. PMID 26851750 DOI: 10.1016/j.canep.2016.01.012  0.32
2016 Earp M, Winham SJ, Larson N, Permuth JB, Sicotte H, Chien J, Anton-Culver H, Bandera EV, Berchuck A, Cook LS, Cramer D, Doherty JA, Goodman MT, Levine DA, Monteiro AN, ... ... Modugno F, et al. A targeted genetic association study of epithelial ovarian cancer susceptibility. Oncotarget. 7: 7381-9. PMID 26848776 DOI: 10.18632/oncotarget.7121  0.32
2016 Winham SJ, Pirie A, Chen YA, Larson MC, Fogarty ZC, Earp MA, Anton-Culver H, Bandera EV, Cramer D, Doherty JA, Goodman MT, Gronwald J, Karlan BY, Kjaer SK, Levine DA, ... ... Modugno F, et al. Investigation of Exomic Variants Associated with Overall Survival in Ovarian Cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 25: 446-54. PMID 26747452 DOI: 10.1158/1055-9965.EPI-15-0240  0.32
2015 Jim HS, Lin HY, Tyrer JP, Lawrenson K, Dennis J, Chornokur G, Chen Z, Chen AY, Permuth-Wey J, Aben KK, Anton-Culver H, Antonenkova N, Bruinsma F, Bandera EV, Bean YT, ... ... Modugno F, et al. Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC). Journal of Genetics and Genome Research. 2. PMID 26807442  0.32
2015 Bolton KL, Tyrer J, Song H, Ramus SJ, Notaridou M, Jones C, Sher T, Gentry-Maharaj A, Wozniak E, Tsai YY, Weidhaas J, Paik D, Van Den Berg DJ, Stram DO, Pearce CL, ... ... Modugno F, et al. Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nature Genetics. 48: 101. PMID 26711112 DOI: 10.1038/ng0116-101b  0.32
2015 Lawrenson K, Iversen ES, Tyrer J, Weber RP, Concannon P, Hazelett DJ, Li Q, Marks JR, Berchuck A, Lee JM, Aben KK, Anton-Culver H, Antonenkova N, ... ... Modugno F, et al. Common Variants at the CHEK2 Gene Locus and Risk of Epithelial Ovarian Cancer. Carcinogenesis. PMID 26424751 DOI: 10.1093/carcin/bgv138  0.32
2015 Liao S, Hartmaier RJ, McGuire KP, Puhalla SL, Luthra S, Chandran UR, Ma T, Bhargava R, Modugno F, Davidson NE, Benz S, Lee AV, Tseng GC, Oesterreich S. The molecular landscape of premenopausal breast cancer. Breast Cancer Research : Bcr. 17: 104. PMID 26251034 DOI: 10.1186/s13058-015-0618-8  0.32
2015 Lu Y, Cuellar G, Painter JN, Nyholt D, Morris AP, Fasching PA, Hein A, Burghaus S, Beckmann MW, Lambrechts D, Van Nieuwenhuysen E, Vergote I, Vanderstichele A, ... ... Modugno F, et al. Shared genetics underlying epidemiological association between endometriosis and ovarian cancer. Human Molecular Genetics. PMID 26231222 DOI: 10.1093/hmg/ddv306  0.32
2015 Johnatty S, Tyrer JP, Kar SP, Beesley J, Lu Y, Gao B, Fasching PA, Hein A, Ekici AB, Beckmann MW, Lambrechts D, Van Nieuwenhuysen E, Vergote I, Lambrechts S, Rossing MA, ... ... Modugno F, et al. Genome-wide analysis identifies novel loci associated with ovarian cancer outcomes: findings from the Ovarian Cancer Association Consortium. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26152742 DOI: 10.1158/1078-0432.CCR-15-0632  0.32
2015 Minlikeeva AN, Freudenheim JL, Lo-Ciganic WH, Eng KH, Friel G, Diergaarde B, Modugno F, Cannioto R, Gower E, Szender JB, Grzankowski K, Odunsi K, Ness RB, Moysich KB. Use of common analgesics is not associated with ovarian cancer survival. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 26063476 DOI: 10.1158/1055-9965.EPI-15-0508  0.32
2015 Pearce CL, Stram DO, Ness RB, Stram DA, Roman LD, Templeman C, Lee AW, Menon U, Fasching PA, McAlpine JN, Doherty JA, Modugno F, Schildkraut JM, Rossing MA, Huntsman DG, et al. Population distribution of lifetime risk of ovarian cancer in the United States. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 24: 671-6. PMID 25623732 DOI: 10.1158/1055-9965.EPI-14-1128  0.32
2014 Kurta ML, Edwards RP, Moysich KB, McDonough K, Bertolet M, Weissfeld JL, Catov JM, Modugno F, Bunker CH, Ness RB, Diergaarde B. Prognosis and conditional disease-free survival among patients with ovarian cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 4102-12. PMID 25403208 DOI: 10.1200/JCO.2014.55.1713  0.32
2014 Kelemen LE, Terry KL, Goodman MT, Webb PM, Bandera EV, McGuire V, Rossing MA, Wang Q, Dicks E, Tyrer JP, Song H, Kupryjanczyk J, Dansonka-Mieszkowska A, Plisiecka-Halasa J, Timorek A, ... ... Modugno F, et al. Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk. Molecular Nutrition & Food Research. 58: 2023-35. PMID 25066213 DOI: 10.1002/mnfr.201400068  0.32
2014 Earp MA, Kelemen LE, Magliocco AM, Swenerton KD, Chenevix-Trench G, Lu Y, Hein A, Ekici AB, Beckmann MW, Fasching PA, Lambrechts D, Despierre E, Vergote I, ... ... Modugno F, et al. Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA. Human Genetics. 133: 481-97. PMID 24190013 DOI: 10.1007/s00439-013-1383-3  0.32
2014 Felix AS, Weissfeld JL, Pfeiffer RM, Modugno F, Black A, Hill LM, Martin J, Sit AS, Sherman ME, Brinton LA. Endometrial thickness and risk of breast and endometrial carcinomas in the prostate, lung, colorectal and ovarian cancer screening trial. International Journal of Cancer. Journal International Du Cancer. 134: 954-60. PMID 23907658 DOI: 10.1002/ijc.28404  0.32
2013 Köbel M, Kalloger SE, Lee S, Duggan MA, Kelemen LE, Prentice L, Kalli KR, Fridley BL, Visscher DW, Keeney GL, Vierkant RA, Cunningham JM, Chow C, Ness RB, Moysich K, ... ... Modugno F, et al. Biomarker-based ovarian carcinoma typing: a histologic investigation in the ovarian tumor tissue analysis consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 1677-86. PMID 23880734 DOI: 10.1158/1055-9965.EPI-13-0391  0.32
2013 Dallal C, Garte S, Ragin C, Chen J, Lloyd S, Modugno F, Weissfeld J, Taioli E. Plasma leptin levels, LEPR Q223R polymorphism and mammographic breast density: a cross-sectional study. The International Journal of Biological Markers. 28: 161-7. PMID 23564622 DOI: 10.5301/jbm.5000016  0.32
2013 Shen H, Fridley BL, Song H, Lawrenson K, Cunningham JM, Ramus SJ, Cicek MS, Tyrer J, Stram D, Larson MC, Köbel M, Ziogas A, Zheng W, Yang HP, ... ... Modugno F, et al. Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nature Communications. 4: 1628. PMID 23535649 DOI: 10.1038/ncomms2629  0.32
2013 Hudson AG, Reeves KW, Modugno F, Wilson JW, Evans RW, Vogel VG, Gierach GL, Simpson J, Weissfeld JL. Erythrocyte omega-6 and omega-3 fatty acids and mammographic breast density. Nutrition and Cancer. 65: 410-6. PMID 23530640 DOI: 10.1080/01635581.2013.760744  0.32
2013 Faber MT, Kjær SK, Dehlendorff C, Chang-Claude J, Andersen KK, Høgdall E, Webb PM, Jordan SJ, Rossing MA, Doherty JA, Lurie G, Thompson PJ, Carney ME, ... ... Modugno F, et al. Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case-control studies. Cancer Causes & Control : Ccc. 24: 989-1004. PMID 23456270 DOI: 10.1007/s10552-013-0174-4  0.32
2012 Modugno F, Edwards RP. Ovarian cancer: Prevention, detection, and treatment of the disease and its recurrence. Molecular mechanisms and personalized medicine meeting report International Journal of Gynecological Cancer. 22. PMID 23013733 DOI: 10.1097/IGC.0b013e31826bd1f2  0.32
2012 Mackey RH, Fanelli TJ, Modugno F, Cauley JA, McTigue KM, Brooks MM, Chlebowski RT, Manson JE, Klug TL, Kip KE, Curb JD, Kuller LH. Hormone therapy, estrogen metabolism, and risk of breast cancer in the Women's Health Initiative Hormone Therapy Trial. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 2022-32. PMID 22933427 DOI: 10.1158/1055-9965.EPI-12-0759  0.32
2012 Kurta ML, Moysich KB, Weissfeld JL, Youk AO, Bunker CH, Edwards RP, Modugno F, Ness RB, Diergaarde B. Use of fertility drugs and risk of ovarian cancer: results from a U.S.-based case-control study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 1282-92. PMID 22707710 DOI: 10.1158/1055-9965.EPI-12-0426  0.32
2011 Reeves KW, Stone RA, Modugno F, Ness RB, Vogel VG, Weissfeld JL, Habel LA, Vuga M, Cauley JA. A method to estimate off-schedule observations in a longitudinal study. Annals of Epidemiology. 21: 297-303. PMID 21376277 DOI: 10.1016/j.annepidem.2010.11.013  0.32
2011 Reeves KW, Weissfeld JL, Modugno F, Diergaarde B. Circulating levels of inflammatory markers and mammographic density among postmenopausal women. Breast Cancer Research and Treatment. 127: 555-63. PMID 21069450 DOI: 10.1007/s10549-010-1249-5  0.32
2010 Bolton KL, Tyrer J, Song H, Ramus SJ, Notaridou M, Jones C, Sher T, Gentry-Maharaj A, Wozniak E, Tsai YY, Weidhaas J, Paik D, Van Den Berg DJ, Stram DO, Pearce CL, ... ... Modugno F, et al. Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nature Genetics. 42: 880-4. PMID 20852633 DOI: 10.1038/ng.666  0.32
2009 Ragin CC, Dallal C, Okobia M, Modugno F, Chen J, Garte S, Taioli E. Leptin levels and leptin receptor polymorphism frequency in healthy populations. Infectious Agents and Cancer. 4: S13. PMID 19208204 DOI: 10.1186/1750-9378-4-S1-S13  0.32
2009 Reeves KW, Ness RB, Stone RA, Weissfeld JL, Vogel VG, Powers RW, Modugno F, Cauley JA. Vascular endothelial growth factor and breast cancer risk. Cancer Causes & Control : Ccc. 20: 375-86. PMID 18987982 DOI: 10.1007/s10552-008-9252-4  0.32
2008 Thomson CA, Neuhouser ML, Shikany JM, Caan BJ, Monk BJ, Mossavar-Rahmani Y, Sarto G, Parker LM, Modugno F, Anderson GL. The role of antioxidants and vitamin A in ovarian cancer: results from the Women's Health Initiative. Nutrition and Cancer. 60: 710-9. PMID 19005970 DOI: 10.1080/01635580802233983  0.32
2008 Oestreicher N, Capra A, Bromberger J, Butler LM, Crandall CJ, Gold EB, Greendale GA, Modugno F, Sternfeld B, Habel LA. Physical activity and mammographic density in a cohort of midlife women. Medicine and Science in Sports and Exercise. 40: 451-6. PMID 18379206 DOI: 10.1249/MSS.0b013e31815f5b47  0.32
2008 Hudson AG, Gierach GL, Modugno F, Simpson J, Wilson JW, Evans RW, Vogel VG, Weissfeld JL. Nonsteroidal anti-inflammatory drug use and serum total estradiol in postmenopausal women. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 680-7. PMID 18349287 DOI: 10.1158/1055-9965.EPI-07-2739  0.32
2008 McTiernan A, Wu L, Barnabei VM, Chen C, Hendrix S, Modugno F, Rohan T, Stanczyk FZ, Wang CY. Relation of demographic factors, menstrual history, reproduction and medication use to sex hormone levels in postmenopausal women. Breast Cancer Research and Treatment. 108: 217-31. PMID 18297397 DOI: 10.1007/s10549-007-9588-6  0.32
2008 Butler LM, Gold EB, Greendale GA, Crandall CJ, Modugno F, Oestreicher N, Quesenberry CP, Habel LA. Menstrual and reproductive factors in relation to mammographic density: the Study of Women's Health Across the Nation (SWAN). Breast Cancer Research and Treatment. 112: 165-74. PMID 18066689 DOI: 10.1007/s10549-007-9840-0  0.32
2007 Reeves KW, Faulkner K, Modugno F, Hillier TA, Bauer DC, Ensrud KE, Cauley JA. Body mass index and mortality among older breast cancer survivors in the study of osteoporotic fractures Cancer Epidemiology Biomarkers and Prevention. 16: 1468-1473. PMID 17627012 DOI: 10.1158/1055-9965.EPI-07-0051  0.32
2007 Reeves KW, Gierach GL, Modugno F. Recreational physical activity and mammographic breast density characteristics. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 934-42. PMID 17507619 DOI: 10.1158/1055-9965.EPI-06-0732  0.32
2007 Habel LA, Capra AM, Oestreicher N, Greendale GA, Cauley JA, Bromberger J, Crandall CJ, Gold EB, Modugno F, Salane M, Quesenberry C, Sternfeld B. Mammographic density in a multiethnic cohort. Menopause (New York, N.Y.). 14: 891-9. PMID 17414171 DOI: 10.1097/gme.0b013e318032569c  0.32
2007 Gayther SA, Song H, Ramus SJ, Kjaer SK, Whittemore AS, Quaye L, Tyrer J, Shadforth D, Hogdall E, Hogdall C, Blaeker J, DiCioccio R, McGuire V, Webb PM, Beesley J, ... ... Modugno F, et al. Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer. Cancer Research. 67: 3027-35. PMID 17409409 DOI: 10.1158/0008-5472.CAN-06-3261  0.32
2007 Wang J, Higuchi R, Modugno F, Li J, Umblas N, Lee J, Lui LY, Ziv E, Tice JA, Cummings SR, Rhees B. Estrogen receptor alpha haplotypes and breast cancer risk in older Caucasian women. Breast Cancer Research and Treatment. 106: 273-80. PMID 17268813 DOI: 10.1007/s10549-007-9497-8  0.32
2006 Zmuda JM, Modugno F, Weissfeld JL, Cauley JA, Trump DL, Moffett SP, Ferrell RE. Peroxisome proliferator-activated receptor-gamma polymorphism, body mass and prostate cancer risk: evidence for gene-environment interaction. Oncology. 70: 185-9. PMID 16763406 DOI: 10.1159/000093805  0.32
2006 Greer JB, Modugno F, Ness RB, Allen GO. Anthropometry and the risk of epithelial ovarian cancer Cancer. 106: 2247-2257. PMID 16596653 DOI: 10.1002/cncr.21830  0.32
2006 Ness RB, Modugno F. Endometriosis as a model for inflammation-hormone interactions in ovarian and breast cancers European Journal of Cancer. 42: 691-703. PMID 16531042 DOI: 10.1016/j.ejca.2006.01.009  0.32
2006 Gierach GL, Modugno F, Ness RB. Gender of offspring and maternal ovarian cancer risk Gynecologic Oncology. 101: 476-480. PMID 16364411 DOI: 10.1016/j.ygyno.2005.11.008  0.32
2006 Modugno F, Ngo DL, Allen GO, Kuller LH, Ness RB, Vogel VG, Costantino JP, Cauley JA. Breast cancer risk factors and mammographic breast density in women over age 70 Breast Cancer Research and Treatment. 97: 157-166. PMID 16362132 DOI: 10.1007/s10549-005-9105-8  0.32
2005 Modugno F, Ness RB, Chen C, Weiss NS. Inflammation and endometrial cancer: A hypothesis Cancer Epidemiology Biomarkers and Prevention. 14: 2840-2847. PMID 16364998 DOI: 10.1158/1055-9965.EPI-05-0493  0.32
2005 Modugno F, Zmuda JM, Potter D, Cai C, Ziv E, Cummings SR, Stone KL, Morin PA, Greene D, Cauley JA. Estrogen metabolizing polymorphisms and breast cancer risk among older white women. Breast Cancer Research and Treatment. 93: 261-70. PMID 16142442 DOI: 10.1007/s10549-005-5347-8  0.32
2005 Greer JB, Modugno F, Allen GO, Ness RB. Short-term oral contraceptive use and the risk of epithelial ovarian cancer American Journal of Epidemiology. 162: 66-72. PMID 15961588 DOI: 10.1093/aje/kwi162  0.32
2005 Modugno F, Zmuda JM, Potter D, Cai C, Ziv E, Cummings SR, Stone KL, Morin PA, Greene D, Cauley JA. Association of estrogen receptor alpha polymorphisms with breast cancer risk in older Caucasian women. International Journal of Cancer. Journal International Du Cancer. 116: 984-91. PMID 15856463 DOI: 10.1002/ijc.21105  0.32
2005 Greer JB, Modugno F, Allen GO, Ness RB. Androgenic progestins in oral contraceptives and the risk of epithelial ovarian cancer Obstetrics and Gynecology. 105: 731-740. PMID 15802398 DOI: 10.1097/01.AOG.0000154152.12088.48  0.32
2005 Gierach GL, Modugno F, Ness RB. Relations of gestational length and timing and type of incomplete pregnancy to ovarian cancer risk American Journal of Epidemiology. 161: 452-461. PMID 15718481 DOI: 10.1093/aje/kwi069  0.32
2004 Modugno F, Ness RB, Allen GO, Schildkraut JM, Davis FG, Goodman MT. Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis. American Journal of Obstetrics and Gynecology. 191: 733-40. PMID 15467532 DOI: 10.1016/j.ajog.2004.03.035  0.32
2004 Baysal BE, DeLoia JA, Willett-Brozick JE, Goodman MT, Brady MF, Modugno F, Lynch HT, Conley YP, Watson P, Gallion HH. Analysis of CHEK2 gene for ovarian cancer susceptibility. Gynecologic Oncology. 95: 62-9. PMID 15385111 DOI: 10.1016/j.ygyno.2004.07.015  0.32
2004 Sit AS, Modugno F, Hill LM, Martin J, Weissfeld JL. Transvaginal ultrasound measurement of endometrial thickness as a biomarker for estrogen exposure. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 13: 1459-65. PMID 15342446  0.32
2003 Modugno F, Ness RB, Allen GO. Alcohol consumption and the risk of mucinous and nonmucinous epithelial ovarian cancer Obstetrics and Gynecology. 102: 1336-1343. PMID 14662224 DOI: 10.1016/j.obstetgynecol.2003.08.008  0.32
2003 Cottreau CM, Ness RB, Modugno F, Allen GO, Goodman MT. Endometriosis and Its Treatment with Danazol or Lupron in Relation to Ovarian Cancer Clinical Cancer Research. 9: 5142-5144. PMID 14613992  0.32
2003 Modugno F, Boyd J, Baum A, Bigbee WL, Cramer D, Ferrell R, Gallion HH, Greene MH, Goldman P, Johnson KA, Junker B, Kuller L, Kurman RJ, Maihle N, Narod S, et al. Ovarian cancer and high-risk women - Implications for prevention, screening, and early detection Gynecologic Oncology. 91: 15-31. PMID 14529658 DOI: 10.1016/S0090-8258(03)00254-3  0.32
2003 Modugno F, Moslehi R, Ness RB, Nelson DB, Belle S, Kant JA, Wheeler JE, Wonderlick A, Fishman D, Karlan B, Risch H, Cramer DW, Dube MP, Narod SA. Reproductive factors and ovarian cancer risk in Jewish BRCA1 and BRCA2 mutation carriers (United States). Cancer Causes & Control : Ccc. 14: 439-46. PMID 12946038 DOI: 10.1023/A:1024932427503  0.32
2003 Modugno F, Ness RB, Ewing S, Cauley JA. Effect of raloxifene on sexual function in older postmenopausal women with osteoporosis. Obstetrics and Gynecology. 101: 353-61. PMID 12576261 DOI: 10.1016/S0029-7844(02)02589-9  0.32
2002 Sit ASY, Modugno F, Weissfeld JL, Berga SL, Ness RB. Hormone replacement therapy formulations and risk of epithelial ovarian carcinoma Gynecologic Oncology. 86: 118-123. PMID 12144815 DOI: 10.1006/gyno.2002.6746  0.32
2002 Modugno F, Ness RB, Cottreau CM. Cigarette smoking and the risk of mucinous and nonmucinous epithelial ovarian cancer Epidemiology. 13: 467-471. PMID 12094103 DOI: 10.1097/00001648-200207000-00016  0.32
Show low-probability matches.